on Medicure, Inc. (NASDAQ:MCUJF)
Medicure to Announce 2024 Financial Results
Winnipeg-based Medicure Inc. will disclose its financial results for the fiscal year ended December 31, 2024, in a conference call scheduled for April 29, 2025. This session will begin at 8:30 AM Eastern Time and is open to stakeholders with the access code 636803. The results will be available on April 28 after market close.
The conference call, accessible via phone and webcast, will include a question-and-answer segment for management to address inquiries related to financial performance. The webcast link is provided on Medicure's website, where a recording will be available post-event.
Medicure focuses on the U.S. market, notably through its products AGGRASTAT® and ZYPITAMAG®, and its pharmacy subsidiary, Marley Drug Inc.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Medicure, Inc. news